Health & Fitness
Mon, November 25, 2024Thu, November 14, 2024Tue, November 12, 2024Sat, June 10, 2017Sat, June 3, 2017Wed, May 31, 2017Wed, May 17, 2017Fri, May 12, 2017Thu, May 11, 2017Tue, May 9, 2017Thu, May 4, 2017Thu, April 20, 2017Fri, April 14, 2017Thu, March 23, 2017Fri, March 17, 2017Thu, March 9, 2017Sat, March 4, 2017Fri, March 3, 2017Thu, March 2, 2017Wed, February 15, 2017Mon, February 13, 2017Wed, February 8, 2017Thu, February 2, 2017Fri, January 13, 2017Wed, January 11, 2017Wed, January 4, 2017Fri, December 16, 2016Thu, December 15, 2016Mon, December 12, 2016Thu, December 8, 2016Wed, November 23, 2016Mon, November 14, 2016Sun, November 13, 2016Wed, November 9, 2016Thu, November 3, 2016Wed, November 2, 2016Mon, October 17, 2016Sat, October 8, 2016Thu, October 6, 2016Wed, October 5, 2016Mon, October 3, 2016Fri, September 30, 2016Thu, September 29, 2016Tue, September 27, 2016Mon, September 26, 2016Fri, September 23, 2016Thu, September 22, 2016Wed, September 21, 2016Tue, September 20, 2016Mon, September 19, 2016Sun, September 18, 2016Fri, September 16, 2016Thu, September 15, 2016Wed, September 14, 2016Mon, September 12, 2016Fri, September 9, 2016Thu, May 9, 2013Wed, May 8, 2013Tue, May 7, 2013Mon, May 6, 2013Sun, May 5, 2013Fri, May 3, 2013Thu, May 2, 2013Wed, May 1, 2013Tue, April 30, 2013Mon, April 29, 2013Sun, April 28, 2013Fri, April 26, 2013Thu, April 25, 2013Wed, April 24, 2013Tue, April 23, 2013Harwood Feffer LLP Announces Investigation of Chemed Corporation
Published in Health and Fitness on Friday, May 3rd 2013 at 16:30 GMT by Market Wire
Harwood Feffer LLP Announces Investigation of Chemed Corporation -- NEW YORK, May 3, 2013 /PRNewswire/ --
NEW YORK, May 3, 2013 /PRNewswire/ -- Harwood Feffer LLP ([ www.hfesq.com ]) is investigating potential claims against the board of directors of Chemed Corporation ("Chemed" or the "Company") (NYSE: [ CHE ]), concerning whether the board has breached its fiduciary duties to shareholders.
(Logo: [ http://photos.prnewswire.com/prnh/20120215/MM54604LOGO ] )
On May 2, 2013, the U.S. Department of Justice (the "DOJ") sued Chemed and certain affiliates alleging that the Company systematically defrauded Medicare. According to the DOJ, the Company aggressively marketed intensive nursing care to patients who did not need it, and then improperly billed Medicare, sometimes for patients who never even received the care. The Company allegedly submitted fraudulent records and statements in support of these and other Medicare claims.
If the Company is found liable in the DOJ suit, it could be forced to pay back three times the amount of money it collected from Medicare, plus at least $5,500 in penalties for each individual false claim submitted to the government.
On this news, Chemed shares fell nearly 20%.
Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own Chemed shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Samuel K. Rosen, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: [ bsachsmichaels@hfesq.com ]
Website: [ http://www.hfesq.com ]
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ([ http://www.hfesq.com ]) for more information about the firm.
Attorney Advertising. © 2013 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ([ www.hfesq.com ]). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP
RELATED LINKS
[ http://www.hfesq.com ]
